Study Conduct

National Stroke Association teams with CureLauncher

Friday, July 26, 2013 08:36 AM

Michigan-based CureLauncher, developer of a patent-pending, proprietary clinical trial matching service, has entered an exclusive partnership with the National Stroke Association—an educational, prevention and advocacy group for individuals, their families and healthcare professionals confronting health issues related to strokes.

More... »

Clinical Research Advantage acquires late phase division of Comprehensive Clinical Development

Wednesday, July 24, 2013 08:29 AM

Tempe, Ariz.-based Clinical Research Advantage (CRA), a wholly owned network of clinical trial sites, has expanded both its geographic and therapeutic reach by acquiring the late phase division of Comprehensive Clinical Development (CCD).

More... »

Healthrageous, United BioSource, Boehringer Ingelheim launch SMART digital diabetes study

Friday, July 19, 2013 01:30 PM

Healthrageous, a digital health management company, and pharmaceutical company Boehringer Ingelheim have launched the SMART study with United BioSource (UBC) to evaluate a digital technology enabled self-management solution to potentially improve the health status of people with type 2 diabetes. The goal of the solution is to leverage technology in a way that makes the personalized journey of self-managing diabetes easier for patients to self-manage their disease.

More... »

Pfizer invests $130 million in two Irish manufacturing sites

Friday, July 12, 2013 02:12 PM

Pfizer is investing $130 million in two of its Irish manufacturing sites, $100 million in the Grange Castle site in Dublin and $30 million in the Ringaskiddy site in Cork. 

More... »

Miami Children's Hospital to use PatientPoint for trial recruitment, enrollment

Tuesday, July 9, 2013 03:10 PM

Cincinnati-based PatientPoint has announced Miami Children's Hospital (MCH) will be the first healthcare provider to use the company's Outcomes Research Solutions (ORS) Platform for clinical trial recruitment and enrollment.

More... »

PhRMA joins National Minority Quality Forum’s collaboration to increase diversity in clinical trials

Monday, July 8, 2013 03:46 PM

Washington, D.C.-based nonprofit The National Minority Quality Forum has announced that the Pharmaceutical Research and Manufacturers of America (PhRMA) has joined the Forum's collaboration with Microsoft to launch The National Clinical Trial Network (NCTN).

More... »

Rutgers, Parexel collaborate to optimize clinical trial services

Monday, July 8, 2013 01:05 PM

Rutgers New Jersey Medical School (NJMS) has been selected by Parexel International, a global biopharmaceutical services provider, as a Key Alliance Site. This will give NJMS ongoing, long-term access to trial opportunities through Parexel’s client base.

More... »

CureLauncher clinical trial matching service teams with Treatment Diaries

Monday, July 8, 2013 09:21 AM

Bloomfield Hills, Mich.-based CureLauncher, which matches people to all enrolling clinical trials, has announced an exclusive partnership with Treatment Diaries, a social but private network anonymously connecting individuals affected by similar illnesses through online health-related conversations captured in personal diaries.

More... »

Moffitt Cancer Center finds language, cultural barriers prevent Hispanic participation in trials

Tuesday, July 2, 2013 03:23 PM

Hispanic cancer patients rarely participate in clinical trials, but researchers want to tailor a Spanish DVD to help change this. To create a relevant educational tool, researchers at the Moffitt Cancer Center in Tampa, Fla., investigated why awareness of and participation in trials are so low in this population.

More... »

Report: British patients participating in clinical research at highest level in six years

Tuesday, July 2, 2013 03:15 PM

A new report released by the National Institute for Health Research Clinical Research Network (the clinical research delivery arm of the NHS) shows that more than 630,000 NHS patients in England took part in clinical research studies last year—the highest level since the Network began keeping track six years ago.

More... »